These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Informative value of varying serum alpha fetoprotein levels in pregnant women based on a screening program in a Hungarian institute. What next?]. Wilhelm O; Lomniczi A; Dudar E; Szöke K; Máj C; Horváth E Orv Hetil; 1992 Dec; 133(51):3243-6. PubMed ID: 1282233 [TBL] [Abstract][Full Text] [Related]
45. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center. Cariati E; Brizzi L; Periti E J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428 [TBL] [Abstract][Full Text] [Related]
46. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)? Sancken U; Bartels I Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279 [TBL] [Abstract][Full Text] [Related]
47. [Proposed normal values for alpha fetoprotein in maternal serum for the detection of neural tube closure defects and Down syndrome. Preliminary study]. Carreras de Paz JJ; Silva Mendoza JM; Violante Diaz M; Cerrillo Hinojosa M; Ahued Ahued JR Ginecol Obstet Mex; 1991 Aug; 59():261-4. PubMed ID: 1722478 [TBL] [Abstract][Full Text] [Related]
48. The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester. Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A Prenat Diagn; 1997 Jul; 17(7):601-6. PubMed ID: 9249859 [TBL] [Abstract][Full Text] [Related]
49. Maternal serum alphafetoprotein screening. University Medical Center. Morris N; Riconda D; Marfatia L; Ostrer H J Fla Med Assoc; 1991 Jun; 78(6):365-8. PubMed ID: 1714937 [TBL] [Abstract][Full Text] [Related]
51. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women. Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126 [TBL] [Abstract][Full Text] [Related]
52. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination. CMAJ; 1994 Jul; 151(2):159-66. PubMed ID: 7518734 [TBL] [Abstract][Full Text] [Related]
53. Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein. Megerian G; Godmilow L; Donnenfeld AE Obstet Gynecol; 1995 Jun; 85(6):952-6. PubMed ID: 7539525 [TBL] [Abstract][Full Text] [Related]
55. Maternal serum alpha-fetoprotein and fetal triploidy. Pircon RA; Towers CV; Porto M; Gocke SE; Garite TJ Prenat Diagn; 1989 Oct; 9(10):701-7. PubMed ID: 2480590 [TBL] [Abstract][Full Text] [Related]
56. Maternal serum alpha-fetoprotein screening programs and quality control for laboratories performing maternal serum and amniotic fluid alpha-fetoprotein assays: policy statement. American Society of Human Genetics. CMAJ; 1987 Jun; 136(12):1253-6. PubMed ID: 2438025 [TBL] [Abstract][Full Text] [Related]